Osteoprotegerin Is a Significant Prognostic Factor for Overall Survival in Patients With Primary Systemic Amyloidosis Independent of the Mayo Staging
Clinical Lymphoma, Myeloma and Leukemia - United States
doi 10.1016/j.clml.2015.07.483
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2015
Authors
Publisher
Elsevier BV